Former GSK Lawyer Acquitted for Making False Statements to FDA
A U.S. District Court judge has acquitted a former GlaxoSmithKline (GSK) lawyer, who was indicted for allegedly obstructing the Food and Drug Administration's investigation into whether the company illegally marketed its anti-depressant drug, Wellbutrin SR. The judge stated that certain…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
documents provided in court that otherwise would have been privileged attorney-client documents were incorrectly obtained using the Crime Fraud Exception. The judge ruled that although Stevens' responses to FDA "may not have been perfect," they were "sent to the FDA in the course of her bona fide legal representation of a client and in good faith reliance of both external and internal lawyers for GSK," and therefore, was acquitted. Court document available by emailing documents@brokerpower.com.